These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20414718)

  • 21. Using mammographic density to improve breast cancer screening outcomes.
    Kavanagh AM; Byrnes GB; Nickson C; Cawson JN; Giles GG; Hopper JL; Gertig DM; English DR
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2818-24. PubMed ID: 18843028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should screen-detected breast cancers be managed differently?
    Krzyzanowska MK; Tannock IF
    J Natl Cancer Inst; 2005 Aug; 97(16):1170-1. PubMed ID: 16106016
    [No Abstract]   [Full Text] [Related]  

  • 23. [Impact of menopause hormone replacement therapy on screening mammography reading].
    Meye NE; Schaffer P; Hédelin G; Guldenfels C; Gairard B
    J Radiol; 2001 Jun; 82(6 Pt 1):653-9. PubMed ID: 11449167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic density and breast cancer risk.
    van Gils CH
    Eur J Obstet Gynecol Reprod Biol; 1999 Oct; 86(2):127-8. PubMed ID: 10509777
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.
    Mackay J; Rogers C; Fielder H; Blamey R; Macmillan D; Boggis C; Brown J; Pharoah PD; Moss S; Day NE; Myles J; Austoker J; Gray J; Cuzick J; Duffy SW
    J Epidemiol Biostat; 2001; 6(5):365-9; discussion 371-5. PubMed ID: 11822726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of menopausal status and use of hormone replacement therapy on radiation dose from mammography in routine breast screening.
    Whitaker CJ; Kelly CM; Faulkner K; Stamp EC
    Br J Radiol; 2006 Jul; 79(943):597-602. PubMed ID: 16823065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Summaries for patients. The effects of age, breast density, and hormone therapy on the accuracy of screening mammograms.
    Ann Intern Med; 2003 Feb; 138(3):I-28. PubMed ID: 12558383
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mammography].
    Grégoire A; Bernard C; Lavallée G; Morin C; Philie M
    Union Med Can; 1992; 121(4):239-42. PubMed ID: 1413293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hormonal replacement therapy and breast cancer].
    This P
    Rev Prat; 2005 Feb; 55(4):377-82. PubMed ID: 15828615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program.
    Hofvind S; Skaane P; Vitak B; Wang H; Thoresen S; Eriksen L; Bjørndal H; Braaten A; Bjurstam N
    Radiology; 2005 Nov; 237(2):437-43. PubMed ID: 16244251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy and mammographic screening.
    Marsden J
    J Br Menopause Soc; 2004 Jun; 10(2):75, 80. PubMed ID: 15207029
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
    Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
    Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast density changes associated with hormone replacement therapy in postmenopausal women. Effects on the specifity and sensitivity of mamographic screening.
    Howard JM
    Eur J Gynaecol Oncol; 2006; 27(1):104; author reply 104. PubMed ID: 16550985
    [No Abstract]   [Full Text] [Related]  

  • 35. Postmenopausal hormone use, screening, and breast cancer: characterization and control of a bias.
    Joffe MM; Byrne C; Colditz GA
    Epidemiology; 2001 Jul; 12(4):429-38. PubMed ID: 11416781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammography screening: views from women and primary care physicians in Crete.
    Trigoni M; Griffiths F; Tsiftsis D; Koumantakis E; Green E; Lionis C
    BMC Womens Health; 2008 Nov; 8():20. PubMed ID: 18990253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.
    Kerlikowske K; Smith-Bindman R; Abraham LA; Lehman CD; Yankaskas BC; Ballard-Barbash R; Barlow WE; Voeks JH; Geller BM; Carney PA; Sickles EA
    Radiology; 2005 Mar; 234(3):684-92. PubMed ID: 15734926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of mammography as a breast cancer screening tool in six districts in France.
    Lacour A; Mamelle N; Lafont S; Bazin B; Dubuc M; Exbrayat C; Trugeon A; Grosclaude P
    Cancer Detect Prev; 1997; 21(5):460-70. PubMed ID: 9307849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT
    Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.